Heart Test Laboratories Inc. (NASDAQ: HSCS) stock jumped 35.43% on Thursday to $1.26 against a previous-day closing price of $0.93. With 0.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 93860.0 shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.2800 whereas the lowest price it dropped to was $0.9200. The 52-week range on HSCS shows that it touched its highest point at $6.00 and its lowest point at $0.71 during that stretch. It currently has a 1-year price target of $3.50.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HSCS was up-trending over the past week, with a rise of 46.84%, but this was up by 43.18% over a month. Three-month performance dropped to -13.70% while six-month performance fell -13.10%. A look at the trailing 12-month EPS for HSCS yields -0.81 with Next year EPS estimates of -1.03. For the next quarter, that number is -0.17. This implies an EPS growth rate of -92.30% for this year and -33.80% for next year.
Float and Shares Shorts:
At present, 8.24 million HSCS shares are outstanding with a float of 5.90 million shares on hand for trading. On May 14, 2023, short shares totaled 0.12 million, which was 1.20% higher than short shares on Apr 13, 2023. In addition to Mr. Andrew Simpson as the firm’s CEO, Pres & Chairman of Directors, Ms. Danielle Watson serves as its CFO & Treasurer.
Institutional Ownership:
Through their ownership of 4.50% of HSCS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 12.13% of HSCS, in contrast to — held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in HSCS with 1.66% of the stake, Oliver LaGore VanValin Investment holds 161,844 shares worth 161,844. A second-largest stockholder of HSCS, AE Wealth Management LLC, holds 149,490 shares, controlling over 1.54% of the firm’s shares. Tradition Wealth Management LLC is the third largest shareholder in HSCS, holding 87,501 shares or 0.90% stake.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jan 30, 2023, HSCS reported revenue of $4.15k and operating income of -$1.98M.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HSCS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HSCS analysts setting a high price target of $4.00 and a low target of $3.50, the average target price over the next 12 months is $3.75. Based on these targets, HSCS could surge 217.46% to reach the target high and rise by 177.78% to reach the target low. Reaching the average price target will result in a growth of 197.62% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
